,
Greetings from
Freyr Qatar
Being reliant on the pharmaceutical imports to encourage the free market competition, Qatar offers good market opportunities for medicinal products and medical devices manufacturers. To enter the region, manufacturers must obtain authorizations from the Ministry of Public Health, Pharmacy and Drug Control Department. However, entering the region challenges the manufacturers with complex Regulatory regime of Qatar.
Freyr with an updated knowledge over the region helps manufacturers navigate the Regulatory complexities for a successful compliance. Freyr’s Regulatory affairs consulting services for Qatar span across:
- Medical Devices
- Pharmaceuticals
Medicinal Products Regulatory Support in Qatar
The Qatar Ministry of Public Health (MoPH), through the Pharmacy & Drug Control Department (PDCD), regulates, evaluates, and authorizes medicinal products in Qatar. Pharmaceutical companies must comply with stringent dossier requirements aligned with GCC-DR / ICH standards, meet local GMP expectations, obtain pricing approvals, and adhere to Arabic labeling regulations.
We provide end-to-end Regulatory support in Qatar—including CTD dossier preparation, GCC submission management, pricing guidance, GMP documentation support, Regulatory pathway strategy, and lifecycle management—helping pharmaceutical companies achieve smooth and compliant market entry.
Freyr Offerings
- Strategic Regulatory Consulting
- Regulatory roadmap for market access
- Regulatory Affairs & Regulatory intelligence
- Registration pathways and license management services
- Pre-submissions Strategies
- Regulatory Submissions (CTD)
- Pharmacovigilance
Freyr Advantages
- Strategic and well-versed local regulatory knowledgebase – with MOH (Pharmacy and Drug Control) Qatar
- Team with 25+ years of strong foothold in the region
- Proven track record for device registrations and submissions
- End-to-end cosmetic Regulatory consultation
- Structured and cost-effective approach to ensure speed to market